Abstract:Seizures after stroke are an important clinical problem and may result in poor outcomes. The indications of antiepileptic drugs (AEDs) for seizure prophylaxis after stroke remain unclear. This is an updated version of the Cochrane Review previously published in 2014. To assess the effects of AEDs for the primary and secondary prevention of seizures after stroke. For primary prevention, we aimed to assess whether AEDs reduce the likelihood of seizures in people who have a stroke but do not have a seizure. For secondary prevention, we aimed to assess whether AEDs reduce the likelihood of further seizures in people who have a stroke and at least one post‐stroke seizure. We searched the following databases on 9 March 2021: Cochrane Register of Studies (CRS Web), MEDLINE (Ovid, 1946 to March 08, 2021). CRS Web includes randomised or quasi‐randomised controlled trials from PubMed, Embase, ClinicalTrials.gov, the World Health Organisation International Clinical Trials Registry Platform (ICTRP), the Cochrane Central Register of Controlled Trials (CENTRAL), and the Specialised Registers of Cochrane Review Groups including Epilepsy and Stroke. We also checked the reference lists of articles retrieved from these searches. We selected randomised and quasi‐randomised controlled studies that recruited participants with a clinical diagnosis of stroke, either ischaemic or haemorrhagic. We excluded studies that only recruited participants with subarachnoid haemorrhage, subdural haemorrhage, extradural haemorrhage, or other non‐stroke diagnoses such as tumour‐ or infection‐related infarction or haemorrhage. We also excluded studies that recruited only participants who had undergone neurosurgery. We included participants of all ages suffering any seizure type who were assigned to AEDs or placebo groups. In accordance with standard methodological procedures expected by The Cochrane Collaboration, two review authors independently assessed trials for inclusion before evaluating trial risk of bias and extracting relevant data. The primary outcome assessed was the proportion of participants who experienced seizures in the follow‐up period. We presented results as summary risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous outcomes and mean differences (MDs) with 95% CIs for continuous outcomes. Where we had sufficient data, we calculated random‐effects (Mantel‐Haenszel) meta‐analyses for dichotomous outcomes; otherwise, we reported results narratively. We used the I 2 statistic to analyse statistical heterogeneity. We planned to use funnel plots to assess publication bias in meta‐analyses with at least 10 included studies. We used the GRADE approach to assess the certainty of the evidence. Two studies with a total of 856 subjects were included. AEDs were not shown to be effective in primary prophylaxis of post‐stroke seizure (RR 0.65, 95% CI 0.34 to 1.26; 2 studies, 856 participants; moderate‐certainty evidence). The first study was a randomised double‐blind study comparing valproic acid with placebo for primary seizure prevention up to one year after stroke. The study included 72 adults with intracerebral haemorrhage. There was no difference in the risk of post‐stroke seizures (RR 0.88, 95% CI 0.35 to 2.16) or of death (RR 1.20, 95% CI 0.40 to 3.58). The second study was a substudy on the use of diazepam in acute stroke. It was a randomised double‐blind study, comparing a three‐day diazepam treatment versus placebo for primary seizure prevention up to three months after stroke in 784 adults with acute stroke. There was no evidence of a difference in the risk of post‐stroke seizures for all stroke or subgroups of haemorrhagic or ischaemic stroke (RR for all stroke 0.47, 95% CI 0.18 to 1.22). In a subgroup analysis of anterior circulation cortical infarcts, primary prophylaxis with diazepam was associated with a reduced risk of post‐stroke seizures (RR 0.21, 95% CI 0.05 to 0.95). Risks of mortality did not differ between the diazepam and the placebo group at two weeks (RR 0.84, 95% CI 0.56 to 1.26) and three months follow‐up (RR 0.95, 95% CI 0.72 to 1.26). We assessed both studies to be at a low overall risk of bias. Using the GRADE approach, we assessed the overall certainty of the evidence as low to moderate. There is insufficient evidence to support the routine use of AEDs on the primary and secondary prevention of seizures after stroke. Further well‐conducted studies are warranted for this important clinical problem. Review question Is there evidence to support the routine use of antiepileptic drugs (AEDs) for the primary and secondary prevention of seizures after stroke? Background Seizures after a stroke are clinically important. It is unclear whether AEDs are effective in preventing seizures after a stroke in adults. Results We found two prospective randomised, double‐blind, placebo‐controlled trials, assessing t -Abstract Truncated-

Evidence-based recommendations for the prophylactic use of antiseizure medications (ASMs) in neurosurgery: a systematic review of guidelines

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

Guidelines and epilepsy practice: Antiseizure medication initiation following an unprovoked first seizure in adults

Use of antiepileptic medications for seizures' prevention during subarachnoid hemorrhage: A retrospective observational study

Guidelines for Seizure Prophylaxis in Adults Hospitalized with Moderate–Severe Traumatic Brain Injury: A Clinical Practice Guideline for Health Care Professionals from the Neurocritical Care Society

[A nationalsurveyandresults analysisof seizure prophylaxis after aneurismal subarachnoid hemorrhage].

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM

Antiepileptic drugs for the primary and secondary prevention of seizures after stroke.

Early Seizure Prophylaxis in Traumatic Brain Injuries Revisited: A Prospective Observational Study

Evaluation and Systematic Review of Guidance Documents for Status Epilepticus

Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures

Development of an Evaluation System for the Prophylactic Use of Antimicrobial Drugs in the Perioperative Period of Class I Surgical Incisions in Neurosurgery

Prophylactic AEDs Treatment for Patients With Supratentorial Meningioma Does Not Reduce the Rate of Perioperative Seizures: A Retrospective Single-Center Cohort Study

Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era

Guidelines in Neurosurgery: a critical appraisal

Pharmacological venous thromboembolism prophylaxis in elective cranial surgery: a systematic review of time of initiation, regimen and duration

A critical appraisal of clinical practice guidelines on pharmacological treatments for spinal cord injury

Evaluating the strength and quality of evidence in american heart association/American stroke association's guidelines for aneurysmal subarachnoid hemorrhage and spontaneous intracerebral hemorrhage

The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study

The Prevalence of Seizures in Brain Metastasis Patients on Anticonvulsant Prophylaxis: A Systematic Review and Meta-Analysis

Immediate and long‐term management practices of acute symptomatic seizures and epileptiform abnormalities: A cross‐sectional international survey